{"id":7112,"date":"2005-09-14T02:17:19","date_gmt":"2005-09-14T01:17:19","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=7112"},"modified":"2014-03-31T16:48:56","modified_gmt":"2014-03-31T16:48:56","slug":"3rd-ias-conference-on-hiv-pathogenesis-and-treatment-24-27-july-2005-rio-de-janeiro-brasil","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/7112","title":{"rendered":"3rd IAS Conference on HIV Pathogenesis and Treatment, 24-27 July 2005, Rio de Janeiro, Brasil"},"content":{"rendered":"<p><strong>This issue of HTB includes reports from this biannual meeting that this year attracted close to 5000 registered delegates.<\/strong><\/p>\n<p>As with many conferences now, many sessions can be viewed on the internet and provide an excellent opportunity for people who unable to attend the meeting.<\/p>\n<p>Daily conference coverage including webcasts and transcripts of plenary sessions, select press conferences and other sessions, and the opening and closing\u00a0ceremonies, has been archived and is available for viewing on:<br \/>\n<a href=\"http:\/\/www.kaisernetwork.org\/rio2005\">http:\/\/www.kaisernetwork.org\/rio2005<\/a><br \/>\nwith links to this site from the IAS conference website:<br \/>\n<a href=\"http:\/\/www.ias-2005.org\/\">http:\/\/www.ias-2005.org<\/a><\/p>\n<p>Abstracts from the meeting are also available to search online although finding them is difficult until AEGiS have completed their archive. Some links from the online programme will access the powerpoint slide used for oral presentations but not the abstracts. The IAS main website also hasn\u0092t added this years meeting to website. Abstracts can be accessed free online in a number of ways:<\/p>\n<ol>\n<li>Via the conference schedule planner: <a href=\"http:\/\/www.ias-2005.org\/planner\/\"> http:\/\/www.ias-2005.org\/planner\/<br \/>\n<\/a>Links via the \u0091programme at a glance\u0092 planner to each section of the programme, include online links to most of the individual abstracts and some of the powerpoint presentations used for the oral sessions.<\/li>\n<li>Via the IAS online abstract archieve: <a href=\"http:\/\/www.iasociety.org\/AbstractSearch.aspx\">http:\/\/www.iasociety.org\/AbstractSearch.aspx<\/a><\/li>\n<li>Using AEGiS conference database: <a href=\"http:\/\/www.aegis.org\/conferences\/iashivpt\/2005\"> http:\/\/www.aegis.org\/conferences\/iashivpt\/2005 <\/a><\/li>\n<\/ol>\n<p>By far the easiest way will be to use the AEGiS online conference database, and although the full programme had not been archived by the time we went to press, it is expected to be available shortly. Careful proofing undertaken by AEGiS often means that many abstracts are more accurate on this excellent non commercial website.<\/p>\n<h2>Reports from the conference<\/h2>\n<ul>\n<li><a title=\"Permanent link to Adult male circumcision reduces transmission rates over 18 months comparable to a vaccine with 65% efficacy\" href=\"https:\/\/i-base.info\/htb\/7106\" rel=\"bookmark\">Adult male circumcision reduces transmission rates over 18 months comparable to a vaccine with 65% efficacy<\/a><\/li>\n<li><a title=\"Permanent link to Benefits of adding 4 or 7 days of AZT\/3TC to single-dose nevirapine to prevent MTCT: further analysis from TOPS\" href=\"https:\/\/i-base.info\/htb\/7104\" rel=\"bookmark\">Benefits of adding 4 or 7 days of AZT\/3TC to single-dose nevirapine to prevent MTCT: further analysis from TOPS<\/a><\/li>\n<li><a title=\"Permanent link to New drugs in pregnancy: atazanavir; T20\" href=\"https:\/\/i-base.info\/htb\/7102\" rel=\"bookmark\">New drugs in pregnancy: atazanavir; T20<\/a><\/li>\n<li><a title=\"Permanent link to Lopinavir\/r use in children less than two years old \u0096 promising results despite low plasma levels\" href=\"https:\/\/i-base.info\/htb\/7100\" rel=\"bookmark\">Lopinavir\/r use in children less than two years old \u0096 promising results despite low plasma levels<\/a><\/li>\n<li><a title=\"Permanent link to Favourable outcomes in children treated with HAART in the MSF programmes\" href=\"https:\/\/i-base.info\/htb\/7098\" rel=\"bookmark\">Favourable outcomes in children treated with HAART in the MSF programmes<\/a><\/li>\n<li><a title=\"Permanent link to Encouraging results with cut up generic fixed dose combination tablets in Uganda\" href=\"https:\/\/i-base.info\/htb\/7096\" rel=\"bookmark\">Encouraging results with cut up generic fixed dose combination tablets in Uganda<\/a><\/li>\n<li><a title=\"Permanent link to Predictors of survival at three years follow up for HIV-infected children in Cote D'Ivoire\" href=\"https:\/\/i-base.info\/htb\/7094\" rel=\"bookmark\">Predictors of survival at three years follow up for HIV-infected children in Cote D&#8217;Ivoire<\/a><\/li>\n<li><a title=\"Permanent link to Benefit of maintaining the M184V mutation with 3TC monotherapy: final 48-week results\" href=\"https:\/\/i-base.info\/htb\/7109\" rel=\"bookmark\">Benefit of maintaining the M184V mutation with 3TC monotherapy: final 48-week results<\/a><\/li>\n<li><a title=\"Permanent link to T20 (enfuvirtide) studies presented at Rio\" href=\"https:\/\/i-base.info\/htb\/7092\" rel=\"bookmark\">T20 (enfuvirtide) studies presented at Rio<\/a><\/li>\n<li><a title=\"Permanent link to Strategies for salvage therapy\" href=\"https:\/\/i-base.info\/htb\/7090\" rel=\"bookmark\">Strategies for salvage therapy<\/a><\/li>\n<li><a title=\"Permanent link to Antiviral activity of foscarnet in salvage patients\" href=\"https:\/\/i-base.info\/htb\/7088\" rel=\"bookmark\">Antiviral activity of foscarnet in salvage patients<\/a><\/li>\n<li><a title=\"Permanent link to Novel strategies with existing drugs\" href=\"https:\/\/i-base.info\/htb\/7086\" rel=\"bookmark\">Novel strategies with existing drugs<\/a><\/li>\n<li><a title=\"Permanent link to Antiretroviral activity of new and novel agents\" href=\"https:\/\/i-base.info\/htb\/7084\" rel=\"bookmark\">Antiretroviral activity of new and novel agents<\/a><\/li>\n<li><a title=\"Permanent link to Overview of pharmacology studies\" href=\"https:\/\/i-base.info\/htb\/7082\" rel=\"bookmark\">Overview of pharmacology studies<\/a><\/li>\n<li><a title=\"Permanent link to Incidence of TB infection despite HAART and treatment in coinfected patients\" href=\"https:\/\/i-base.info\/htb\/7080\" rel=\"bookmark\">Incidence of TB infection despite HAART and treatment in coinfected patients<\/a><\/li>\n<li><a title=\"Permanent link to Evaluation of ESAT-6 and CFP-10 as markers for response to TB treatment in HIV\/TB coinfected patients\" href=\"https:\/\/i-base.info\/htb\/7078\" rel=\"bookmark\">Evaluation of ESAT-6 and CFP-10 as markers for response to TB treatment in HIV\/TB coinfected patients<\/a><\/li>\n<li><a title=\"Permanent link to Does WHO clinical stage reliably predict who should receive ARV treatment?\" href=\"https:\/\/i-base.info\/htb\/7076\" rel=\"bookmark\">Does WHO clinical stage reliably predict who should receive ARV treatment?<\/a><\/li>\n<li><a title=\"Permanent link to Continuous vs intermittent treatment with triple nuke combination of AZT\/3TC\/tenofovir in Africa: early results from DART study\" href=\"https:\/\/i-base.info\/htb\/7074\" rel=\"bookmark\">Continuous vs intermittent treatment with triple nuke combination of AZT\/3TC\/tenofovir in Africa: early results from DART study<\/a><\/li>\n<\/ul>\n\n","protected":false},"excerpt":{"rendered":"<p>This issue of HTB includes reports from this biannual meeting that this year attracted close to 5000 registered delegates. As with many conferences now, many sessions can be viewed on the internet and provide an excellent opportunity for people who &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,91],"class_list":["post-7112","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-ias-3rd-2005"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/7112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=7112"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/7112\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=7112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=7112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=7112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}